(Q34669625)

3 August 2017

1 reference

title

Structural biology in drug design: selective protein kinase inhibitors (English)

1 reference

3 August 2017

0 references

1 reference

Giovanna Scapin

1

1 reference

3 August 2017

publication date

1 June 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

7

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

601-611

1 reference

Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structural basis for control by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Protein tyrosine phosphatases in signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Protein phosphatases--a phylogenetic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Molecular reactions of protein phosphatases--insights from structure and chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Histidine phosphorylation and two-component signaling in eukaryotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Growth factor signaling by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Protein tyrosine kinase structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

1 reference

7 January 2021

Crystal Structure of the Catalytic Subunit of Cyclic Adenosine Monophosphate-Dependent Protein Kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Active and inactive protein kinases: structural basis for regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Kinetic and catalytic mechanisms of protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

RTK mutations and human syndromeswhen good receptors turn bad.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Molecular and cellular interactions in rheumatoid synovium.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Protein kinase inhibition: natural and synthetic variations on a theme

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Chemical inhibitors of protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Protein kinase inhibitors: the tyrosine-specific protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

The Src homology-2 domains (SH2 domains) of the protein tyrosine kinase p56lck: structure, mechanism and drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Recent advances in the design and synthesis of SH2 inhibitors of Src, Grb2 and ZAP-70.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Progress in the development of inhibitors of SH2 domains

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

From consensus sequence peptide to high affinity ligand, a "library scan" strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Substrate competitive inhibitors of IGF-1 receptor kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Mechanism-based design of a protein kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structural basis of inhibitor selectivity in MAP kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structural basis for selective inhibition of Src family kinases by PP1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

The cell cycle and drug discovery: the promise and the hope

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Therapeutic potential of targeting the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structure-based design of potent CDK1 inhibitors derived from olomoucine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Identification of cylin-dependent kinase 1 inhibitors of a new chemical type by structure-based design and database searching

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Strategies toward the design of novel and selective protein tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide]

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

The protein kinase C family: heterogeneity and its implications

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Modular peptide recognition domains in eukaryotic signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Rational design, synthesis, and biological evaluation of rigid pyrrolidone analogues as potential inhibitors of prostate cancer cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Src homology-2 domains: structure, mechanisms, and drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structure-based design and synthesis of a novel class of Src SH2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structure-based design of novel bicyclic nonpeptide inhibitors for the src SH2 domain.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

Crystal structure of the cys2 activator-binding domain of protein kinase C delta in complex with phorbol ester

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902290-0

7 January 2021

10.1016/S1359-6446(02)02290-0

Identifiers

DOI

1 reference

3 August 2017

1 reference